You are here
By Hiroshi Kawaguchi, MD, PhD, George Nuki, MB, FRCP
Kawaguchi: This roundtable discussion is on the Osteoarthritis Research Society International (OARSI) treatment guidelines, of which part 1 has just been published this year and part 2 on consensus recommendations will be published early in 2008. First of all, please could you give a brief outline of the OARSI treatment guidelines, especially in comparison with the former osteoarthritis (OA)...
By Hiroshi Kawaguchi, MD, PhD, Steven Abramson, MD, George Nuki, MB, FRCP
The incidence of osteoarthritis (OA) has been increasing on a global scale. Research is under way to elucidate its causes and pathology; however, no fundamental treatment methods have been established. This roundtable discussion involved leading physicians from the USA, the UK, and Japan, who talked frankly about the current status of and outlook for OA treatment from
By Joseph A. Buckwalter, MD, Stefan Lohmander, MD, Hiroshi Kawaguchi, MD, PhD
Recent advances in bioscience at the molecular level and research methods have brought with them a dramatic growth in the volume of medical research conducted at various levels in ever-diversifying specializations. Orthopedics is, of course, no exception; attempts to further explore this therapeutic area have resulted in remarkable progress, with state-of-the-art research in orthopedics now...
By Weiya Zhang, BSc, MSc, PhD, Byoung-Hyun Min, MD, PhD, Qing Jiang, MD, PhD, Hiroshi Kawaguchi, MD, PhD
This newsletter has been covering the efforts of the Osteoarthritis Research Society International (OARSI) to optimize treatment for patients with osteoarthritis (OA) worldwide. In 2008, OARSI published its expert consensus recommendations for the management of OA of the hip and knee (Part 2)1, based on an appraisal of existing guidelines and a systematic review of evidence for relevant...
- 1 of 9